Name
Integrating Available Medications in Primary Care for management of Fatty Liver disease
Date & Time
Thursday, December 4, 2025, 7:55 PM - 8:25 PM
James Kim Alnoor Ramji
Description
  • Role of GLP-1s, statins, insulin sensitizers, and upcoming MASH therapies
  • Considerations for T2D, obesity, CKD, and polypharmacy
  • What’s in the pipeline
  • Diabetes Canada Guidelines / CanMASLD Guidelines?